stars 1 stars 2 stars 3

ArcticDx Inc. is a molecular diagnostic company with expertise in the design, development and commercialization of validated molecular diagnostic tests. Our business model is focused towards the rapid commercialization of Intellectual Property (IP) from international gene discovery programs. ArcticDx: 1.Acquires validated molecular IP; 2.Validates and commercializes customized diganostic tests; 3.Out-licenses validated diagnostic tests internationally. Macula Risk® PGx is a combined prognostic and pharmacogenetic DNA test designed to determine a patient’s risk of progression to advanced Age-related Macular Degeneration (AMD) and aid in the selection of appropriate eye vitamins for AMD based on his or her individual genetic risk profile. Macula Risk PGx and Vita Risk™ are covered by most insurers for patients with a diagnosis of AMD.

ArcticDx Questions

The ArcticDx annual revenue was $5.4 million in 2026.

3 people are employed at ArcticDx.

ArcticDx is based in Toronto, Ontario.

The NAICS codes for ArcticDx are [32541, 3254, 32, 325].

The SIC codes for ArcticDx are [283, 28].

Top ArcticDx Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users